Search Results Search Sort by RelevanceMost Recent Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. In the Literature Jun 2008 Managing Difficult Behaviors in Patients with Dementia Richard Hwang Virtual Mentor. 2008;10(6):379-382. doi: 10.1001/virtualmentor.2008.10.6.disc1-0806. Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 1 Mark Tonelli, MD, MA Virtual Mentor. 2004;6(12):542-544. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412. Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 2 Erin Egan, MD, JD Virtual Mentor. 2004;6(12):544-546. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. History of Medicine Jul 2017 Framing Confusion: Dementia, Society, and History Jesse F. Ballenger, PhD, MA Viewing dementia as a distinct disease promotes funding for research but may stigmatize those who have dementia and lead to disinvestment in caregiving. AMA J Ethics. 2017;19(7):713-719. doi: 10.1001/journalofethics.2017.19.7.mhst1-1707. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
In the Literature Jun 2008 Managing Difficult Behaviors in Patients with Dementia Richard Hwang Virtual Mentor. 2008;10(6):379-382. doi: 10.1001/virtualmentor.2008.10.6.disc1-0806.
Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 1 Mark Tonelli, MD, MA Virtual Mentor. 2004;6(12):542-544. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412.
Case and Commentary Dec 2004 Preoperative Screening: Medical or Legal Guidelines? Commentary 2 Erin Egan, MD, JD Virtual Mentor. 2004;6(12):544-546. doi: 10.1001/virtualmentor.2004.6.12.ccas3-0412.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
History of Medicine Jul 2017 Framing Confusion: Dementia, Society, and History Jesse F. Ballenger, PhD, MA Viewing dementia as a distinct disease promotes funding for research but may stigmatize those who have dementia and lead to disinvestment in caregiving. AMA J Ethics. 2017;19(7):713-719. doi: 10.1001/journalofethics.2017.19.7.mhst1-1707.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.